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The M2 isoform of pyruvate kinase, the ﬁnal rate-limiting enzyme of aerobic glycolysis, is expressed
during embryonic development. In contrast, the M1 isoform is expressed in differentiated cells due to
alternative splicing. Here we investigated murine embryonic stem cells (ESCs) with Pkm1 or Pkm2 knock-
in alleles. Pkm1 allele knock-in resulted in excessive oxidative phosphorylation and induced the for-
mation of cysteine-thiol disulﬁde-dependent complexes of forkhead box class-O (FOXO) transcription
factors, which resulted in altered endoderm differentiation. In contrast, Pkm2 knock-in induced synthesis
of a methylation-donor, S-adenosylmethionine, and increased unsaturated eicosanoid groups, which
contributed to the redox control and maintenance of ESC undifferentiated status. Because PKM2 is also a
critical enzyme for the cancer-speciﬁc Warburg effect, our results demonstrate an important role for the
Pkm2 allele in establishing intracellular redox conditions and modulating PKM1-dependent oxidative
phosphorylation events to achieve an appropriate ESC differentiation program.
© 2015, The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V. All
rights reserved.1. Introduction
In mammals, there are four isoforms of pyruvate kinase (PK):
PKM1, PKM2, PKL, and PKR [1e3]. PKL and PKR genes on mouse
chromosome 3 are controlled by tissue-speciﬁc promoters in liver
and red blood cells, respectively [4]. PKM1 and PKM2 genes onﬁling Discovery, Osaka Uni-
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ative Medicine. Production and homouse chromosome 9 are preferentially expressed in various cells
and are the result of alternative splicing of a single PK gene. PKM1
and PKM2 transcripts include exons 9 and 10, respectively [5]. PK
expression is tightly regulated according to the particular tissues
involved and developmental stages [3]. Although each PK isozyme
plays a role in the metabolism in various cells [4], PKM2 is uniquely
expressed in early fetal tissues, including undifferentiated embry-
onic stem cells (ESCs), but it is also expressed in most adult tissues,
suggesting that PKM2 is a prototype enzyme during mammalian
development [5,6].
The PKM2 isoform gradually switches to the PKM1 isoform in
skeletal muscle, heart, and brain in a developmental stage-
dependent manner. Carcinogenesis apparently reverses this pro-
cess [7]. During tumor development, tissue-speciﬁc enzyme ex-
pressions, such as those of PKM1 in brain and PKL in the liver, are
decreased, whereas PKM2 expression is increased and is frequentlysting by Elsevier B.V. All rights reserved.
M. Konno et al. / Regenerative Therapy 1 (2015) 63e7164altered in numerous tumors [4,8]. Proliferating cells, particularly
cancer cells, express the PKM2 isoform [4].
Cell metabolism plays a pivotal role in determining whether a
cell would proliferate, differentiate, or remain in an undifferenti-
ated state. A particular biochemical characteristic thatFig. 1. PK pathway affects cellular differentiation. Schematic representation of homologous
PKM1 and PKM2 derived from alternative slicing for maintaining pluripotency and controlli
(C, D, E) Gene expression patterns during early differentiation of Pkm1KI and Pkm2KI ESCs th
(B), mesoderm (C), and ectoderm (E) were examined.distinguishes cancer cells and induced pluripotent stem cells (PSCs)
from differentiated cells is their metabolic regulation, which is
characterized by limited oxidative capacity and active anaerobic
glycolysis [9]. Proliferative ESCs and cancer cells exhibit high
glycolysis rates, which result in lactate production despite highrecombination of Pkm1KI and Pkm2KI alleles in ESCs. Experimental scheme. Roles of
ng early differentiation. Pkm1KI and Pkm2KI embryonic stem cells (ESCs) were studied.
at were cultured in medium without LIF. Speciﬁc differentiation markers for endoderm
M. Konno et al. / Regenerative Therapy 1 (2015) 63e71 65oxygen levels. Recent studies have suggested a critical role for
epigenetics during stem cell differentiation relative to differenti-
ated cells [10], including upregulated expression of threonine de-
hydrogenase (TDH) in early blastocysts and ESCs and induced PSC
reprogramming [11,12]. TDH and glycine dehydrogenase regulate 5-
methyltetrahydrofolate synthesis, thereby modulating histone H3
lysine 4 (H3K4) trimethylation [9]. H3K4 trimethylation is associ-
ated with open euchromatin, which is crucial for PSC epigenetic
plasticity and self-renewal via their gene expression [13,14]. This
indicates that there is a close association between stem cell
metabolism and differentiation.Fig. 2. PKM splicing affects ESC differentiation. Expression array analysis of Pkm1KI, Pkm2K
GSEA analysis of Pkm1KI and Pkm2KI ESCs. Data for cells cultured in differentiation medium f
differentiation gene set signatures were enriched in Pkm1KI cells (left), whereas undiffere
conﬁrmed using another V6.5 cell line, as shown in the bottom two panels (Hailesellasse-SIn this study, we investigated murine ESCs with stable Pkm1 or
Pkm2 knock-in for one allele at a time (here denoted Pkm1KI and
Pkm2KI, respectively). Pkm2KI ESCs were difﬁcult to differentiate
into early mesoderm and endoderm lineages as compared with
wild type (WT) ESCs and Pkm1KI ESCs. However, WT and Pkm1KI
ESCs successfully differentiated into speciﬁc lineages, such as
pancreatic cells, as compared with Pkm2 knock-in ESCs. PKM2
expression induced synthesis of a methylation-donor, S-adeno-
sylmethionine (SAM), and oxidation that promoted the formation
of cysteine-thiol disulﬁde-dependent complexes of FOXO tran-
scription factors and p300/CBP. Thus, our data suggest that PKM1I, and WT embryonic stem cells (ESCs) under differentiation conditions (days 3 and 7).
or 7 days are shown. For the J1 cell line (top two panels; Hailesellasse-Sene et al., 2007),
ntiated gene set signatures were enriched in Pkm2KI cells (right). These results were
ene et al., 2007).
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may modulate oxidative phosphorylation effects to maintain ESC
immature metabolism status at a branching stage for differentia-
tion into speciﬁc cell lineages.
2. Results and discussion
2.1. Alternative Pk alleles control ESC differentiation
To unravel the stabilizing effect of PK on differentiation, we
cultured Pkm1-knock-in (for one allele; the other allele was wild
type; Pkm1KI ESCs), Pkm2-knock-in (for one allele; the other allele
was wild type; Pkm2KI ESCs), and normal control ESC lines under
differentiation-inducing conditions (Fig. 1AB). The expressions of
FOXA2, a-fetoprotein (AFP), and HINF1B (endoderm markers), and
BMP2 and SOX17 (mesoderm) were markedly increased in Pkm1KI
ESCs in a time-dependent manner, whereas HOXA1, OTX2, PAX6,
and Neurogenin 2 (ectoderm) expressions were context dependent
(Fig. 1CeE). Microarray data (GSE57504) for cells cultured in
differentiation-inducing medium for 7 days indicated that the ex-
pressions of metabolism-related genes in Pkm1KI ESCs were similar
to those in WT ESCs but not those in Pkm2KI ESCs (Fig. 2A, Fig. S1).
This GSEA analysis revealed that differentiation marker gene ex-
pressions [15] were enriched in Pkm1KI ESCs as compared with
Pkm2KI ESCs at day 7 (Fig. 2B). This suggested that the PKM2 iso-
form contributed to modulating against induced ESC
differentiation.
2.2. PKM2 enhances methionine metabolism during ESC
differentiation
To determine the differences in metabolism between Pkm1KI
and Pkm2KI ESCs during differentiation, we analyzed the metab-
olomes of WT, Pkm1KI, and Pkm2KI ESCs for 0, 3, and 7 days that
were cultured without LIF in vitro using liquid chromatography-
electrospray ionized time-of-ﬂight MS (LCeMS). It was previously
shown that oxidative stress inﬂuenced the function of transcription
factor networks, such as FOXO, by altering the expression of
downstream target genes, such as Pdx1 and Fbxo32 [16,17]. How-
ever, the basic metabolite dynamics in response to PKM1-
dependent oxidative phosphorylation during early development
remain unclear. Thus, we investigated the early-stage metabolomes
of ESCs (Fig. 3, Figs.S2, S3). Principal component analysis showed
that the glutathione pathway was enhanced and that SAM levels
were higher in Pkm2KI ESCs at days 0, 3, and 7 than those in con-
trols (Fig. 3, Figs.S2, S3). SAM is important for H3K4 di- or trime-
thylation and euchromatin formation [11]. Because the ratio of
SAM:S-adenosyl homocysteine was high, SAM may have played a
role in maintaining histone methylation events during the early
differentiation of Pkm2KI ESCs. Thus, we hypothesized that PKM2
may have a pivotal role in modulating oxidative stress-induced
mechanism.
2.3. PKM2 controls pro-oxidative events during ESC differentiation
Principal component analysis also showed that lactate was the
predominant metabolite in WT and Pkm2KI ESCs but not in Pkm1KI
ESCs. Pluripotent ESCs are enriched in unsaturated lipids (i.e., u3
and u6) that contain readily oxidizable carbonecarbon doubleFig. 3. PKM1 and PKM2 effects on cell metabolomes during early differentiation (Day 7). Em
cultured for 7 days without LIF. Principal component analysis results indicated a good sepa
Pkm2KI ESCs shown as loading factors (labeled colors). Loading (1 < FL < 1) factors indica
number was small, this was regarded as an important metabolic product of Pkm1KI cells.bonds [18]. Our LCeMS analysis showed that levels of unsaturated
metabolites, such as linoleic acid, linolenic acid, docosapentaenoic
acid, prostaglandin E2, arachidonic acid, and eicosapentaenoic acid
(but not saturated acids), increased more in Pkm2KI ESCs than in
Pkm1KI and WT ESCs in a time-dependent manner under differ-
entiation conditions (Fig. 4A). These data strongly suggested that
the Pkm2KI allele contributed to maintaining unsaturated lipid
levels. Although a recent study indicated that highly unsaturated
metabolites may be susceptible to pro-oxidative events [18], it re-
mains unclear if this causes or results from the conditions of ESC
differentiation; thus, we investigated if oxidation modulated the
transcription response, which is critical for ESC differentiation.2.4. Alternative PKM1 and PKM2 splicing determines oxidation-
dependent cysteine bridge FOXO transcription factors during ESC
differentiation
Principal component analysis showed that the levels of cystine
(sensitive to oxidation) were higher at days 3 and 7 than at day 0,
which suggested that redox-sensitive modulation had occurred
during ESC differentiation (Fig. 3, Figs.S2, S3). In general, cysteine
oxidation of transcription factors affects DNA binding and the
transcription activity of several nuclear factors, including
activating-protein-1 (AP-1), nuclear factor-kB (NF-kB), p53,
hypoxia-inducible factor (HIF) [19], and forkhead box class-O
(FOXO) transcription factors [16]. Transcriptome pathway analysis
has indicated that gene sets are enriched in the pancreatic PDX1
pathway [17] and the cardiocyte atrogin pathway [20], which are
downstream of FOXO.
FOXO activity is inhibited by hydrogen peroxide (H2O2) by two
independent mechanisms [21]: 1) FOXO associates with p300/CBP
histone acetyltransferase via an intracellular disulﬁde bond, fol-
lowed by protein acetylation and impaired transcriptional activity
[16], which results in attenuated suppression of PDX1-dependent
b-cell proliferation and failure against oxidative stress [17]; 2) An
indirect mechanism of ROS-dependent phosphorylation of FOXO by
Akt, which results in nuclear exclusion of this factor [22,23] and
causes in vitro alterations in cardiocyte modeling [20].
To determine if PK axis oxidation induced cysteine-thiol disul-
ﬁde-dependent complexes of FOXO transcription factors and p300/
CBPwere involved, we taggedmutant vectors and transfected these
into Pkm1KI, Pkm2KI, andWT ESCs. These cells were cultured in LIF-
free medium to induce their differentiation and then subjected to
immunoblot analysis. FOXO4 contains 5 cysteine residues (at po-
sitions 27, 239, 355, 411, and 477) and is involved in redox-
dependent heterodimerization to p300 (1:1 ratio) via Cys477 to
p300/CBP binding under exogenous H2O2 exposure [16]. We used 5
mutants, in which 4 of the 5 cysteine residues were mutated to
serine residues, which left a single unaltered cysteine residue [e.g.,
denoted FOXO4(Dþ27), excluding Cys27].
Under nonreducing conditions, both FLAG-FOXO4 (WT) and
FOXO4 (Dþ27) associated with HA-p300/CBP in Pkm1KI and WT
ESCs as a slowly mobilized band. This association was reduced in
FOXO4 (WT) and was undetectable in FOXO4 (Dþ27) in Pkm2KI
ESCs, and it disappeared and showed only a single p300/CBP band
under reducing conditions (Fig. 4B). Thus, Cys27 was probably
involved in binding to p300/CBP under endogenous PKM1-derived
redox regulation in ESCs, which may have been a condition distinct
from exogenous peroxide-induced alteration of Cys477 in HEK293Tbryoid bodies were prepared from Pkm1KI and Pkm2KI embryonic stem cells (ESCs) and
ration between Pkm1KI and Pkm2KI ESCs. Comparison of all metabolites of Pkm1KI vs.
ted the importance of each variable to account for the variability in PC1. When the FL
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chemistry results for embryoid bodies cultured without LIF for 7
days showed that the nonregulation of Pdx1 was considerably
increased during pancreatic lineage differentiation of mutant ESCs
(Fig. 4C), which suggested that early differentiation was attenuated
by oxidative phosphorylation.
FOXO family inhibits unscheduled b-cell proliferation by sup-
pressing PDX1 by competing with FOXA2 on the PDX1 promoter
sequence [17]. To determine the importance of the PDX1 promoter
sequence with a FOXO4 binding site, a luciferase reporter assay was
performed using the mouse insulinoma cell line Min6 that
expressed Pdx1. Luciferase activity was reduced due to a mutation
in the FOXO4 binding site. This suggested that FOXO4 was an
important factor for Pdx1 gene expression (Fig. 4D, E). Thus, the
association of FOXO with p300/CBP might have impaired tran-
scriptional function and protected against b-cell failure due to
oxidative stress.
In addition, Akt was phosphorylated, and it attenuated the
transcriptional activity of downstream F-box only protein 32, an
important factor for cardiocyte remodeling [20] in Pkm1KI ESCs
(data not shown). The role of PKM2 was conﬁrmed by expression
proﬁling during early differentiation, which was considerably
different from those in Pkm1KI and WT ESCs. The PK axis appeared
to play a pivotal role during differentiation via oxidative-sensitive
FOXO transcription factors (Fig. 4F).
In conclusion, the present study results demonstrated that
PKM2 contributed to ﬁne-tuning controls of oxidative phosphory-
lation during the early stages of ESC differentiation of which
mechanismsmay be deleteriously altered in numerous cancer cells.3. Methods
3.1. Cell culture and transfection
PKM knock-in ESCs and normal ESCs (v6.5 cell lines) were
cultured in high-glucose DMEM (Nacalai Tesque) supplemented
with 15% FBS (Nitirei), 1 mM sodium pyruvate solution (Gibco), 1
MEM nonessential amino acids (Gibco), 0.1 mM 2-mercaptoethanol
(Nakarai), and 1000 U/ml of ESGRO (Millipore) on mitomycin
treated MEF feeder cells at 37 C in a CO2 incubator. The Min6 cell
line was cultured in DMEM (high-glucose) supplemented with 10%
FBS (Nitirei) and 0.1 mM 2-mercaptoethanol.3.2. Genetic recombination in ESCs
Knock-in and knock-out Pkm1 and Pkm2 ESCs were generated by
homologous recombination. Knock-in and knock-out ESCs for
PKM1 and PKM2 were generated by homologous recombination of
exon 9 with poly A tailed cDNA to disrupt splicing to exon 10
(Pkm1KI ESCs) and by homologous recombination of exon 10 with
poly A tailed cDNA to disrupt splicing to exon 9 (Pkm2KI ESCs). ESCs
were maintained in embryonic stem cell (ESC) medium supple-
mented with LIF and ESC certiﬁed serum (Invitrogen Life Technol-
ogies Japan, Tokyo, Japan). Our experimental protocols were
approved by our Institutional Committee for Animal Use.Fig. 4. PKM splicing is involved in redox control. Saturated and unsaturated fatty acids deter
differentiation protocol for the indicated times. Numbers of unsaturated carbon bonds are sh
Wild-type (WT) and mutants (6) of Pkm1KI, Pkm2KI, and WT embryonic stem cells (ESCs)
analysis of PDX1 expression with and without LIF or pancreatic differentiation of Pkm1KI, Pkm
inserted upstream of the luciferase sequence. FOXO4 binding nucleotides were substituted i
redox regulation of unsaturated metabolites in response to oxidative phosphorylation. In
differentiation progression. PKM1 and PKM2 orchestration may contribute to the terminal3.3. ESC differentiation
After culturing, ESCs were trypsinized, and embryoid bodies
(EBs) were generated by the 3-D hanging drop method (Day 0).
Brieﬂy, EBs were grown in hanging drops for 2 days (Day 0 to Day
2), each of which initially included 500 cells in 19 mL of EB differ-
entiation medium. EBs were cultured in DMEM medium (Nacalai
Tesque, Kyoto, Japan) supplemented with 10% FBS and 0.08 mM 2-
mercaptoethanol on an ultra-low attachment dish for 5 days (days
3e7). Pancreatic cell differentiation was performed using the
methods described by Nakanishi et al. [24].
3.4. RNA analysis
Total RNAwas extracted using phenol, followed by precipitation
(TRIzol kit, Invitrogen Life Technologies Japan, Tokyo, Japan). cDNA
was synthesized and used for quantitative real-time polymerase
chain reaction (qRT-PCR) with a Light Cycler (Roche). Ampliﬁed
signals were normalized against b-actin signals.
3.5. RT-PCR
The expressions of marker genes for differentiation, HOXA1,
OTX2, PAX6, and NEUROG2 (ectoderm), BMP2 and SOX17 (meso-
derm), AFP, HNF1B, and FOXA2 (endoderm), were determined by
RT-PCR. Total RNA was extracted using Trizol (Life Technologies),
according to the manufacturer's instructions and then treated with
ReverTra Ace qRT-PCR Master Mix with gDNA Remover (Toyobo) to
generate cDNA. qRT-PCR ampliﬁcation was performed using Light
Cycler FastStart DNA Master SYBR Green I (Roche). Primers used in
this study were: HOXA1 (50-CTACTCCAGCCCAACTCTGC-30 and 50-
AATTGATGTGGACACCCGAT-30), OTX2 (50-ACCAGCAACCTGAAATG-
GAC-30 and 50-CCTGTTGGTCATGAAACGTG-30), PAX6 (50-AACAACC
TGCCTATGCAACC-30 and 50-ACTTGGACGGGAACTGACAC-30), NEU-
ROG2 (50-GCTGTGGGAATTTCACCTGT-30 and 50-CCTGGCCCTCTAA-
CAAAACA-30), BMP2 (50-TGGAAGTGGCCCATTTAGAG-30 and 50-
GCTTTTCTCGTTTGTGGAGC-30), SOX17 (50-ACCCTAAACACAAA-
CAGCGG-30 and 50-GCAGGTGTCGAGATGACTGA-30), AFP (50-GAAG-
CAAGCCCTGTGAACTC-30 and 50-CCGAGAAATCTGCAGTGACA-30),
HNF1B (50-GATGTCAGGAGTGCGCTACA-30 and 50-CTGAGATTGCTG
GGGATTGT-30), FOXA2 (50-GGATCATGGACCTCTTCCCT-30 and 50-
GGCACCTTGAGAAAGCAGTC-30), GLUCAGON (50-GCACATTCACCAG
CGACTACAG-30 and 50-GGGAAAGGTCCCTTCAGCATGTCT-30), and b-
actin (50-GTAGCTGTCTTCAGACACTCC-30 and 50-AATTA-
GAGCTATGCAGAGAAA-30).
3.6. miRNA microarray experiments
For miRNA microarray experiments, after assessments for
quality, 500 ng of extracted total RNA was labeled with Cyanine-3
(Cy3) using a Low Input Quick Amp Labeling Kit (Agilent). Dye
incorporation and cRNAyields were checked using a NanoDrop ND-
2000 Spectrophotometer. Labeled RNAs were hybridized on an
Agilent Mouse GE 860K Microarray at 65 C for 17 h in a rotating
Agilent hybridization oven. After hybridization, microarrays were
washed with GE Wash Buffer 1 (Agilent, Tokyo, Japan) at room
temperature for 1 min and with GEWash buffer 2 (Agilent) at 37 Cmined by mass spectroscopy. Pkm1KI, Pkm2KI, and WT ESCs were subjected to the early
own at the bottom. (B) Redox-dependent heterodimerization of FOXO4 with p300/CBP.
were studied under reducing and nonreducing conditions. (C) Immunocytochemical
2KI, and WT ESCs. (D, E) Luciferase reporter activity. The PDX1 promoter sequence was
n a mutant vector. (F) Proposed scheme for a PKM splicing effect. PKM2 contributes to
the pancreas, PKM2 inhibits unscheduled events by preventing Pdx1-induced excess
differentiation of somatic cells.
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thorough washes with GE Wash Buffer 1 (Agilent) and GE Wash
buffer 2 (Agilent) for 1 min each, ﬂuorescent signals were scanned
with an Agilent DNA Microarray Scanner (G2565CA) and analyzed
using Feature Extraction Software 10.10 (Agilent).
3.7. Western blot analysis
Cells were lysed in a buffer containing EDTA-free protease in-
hibitors (Sigma Aldrich, Tokyo, Japan; 50 mM HEPES, pH 7.5,
150 mM NaCl, and 1% Triton X-100). Protein concentrations were
determined with a protein assay kit (BioRad, Tokyo, Japan). Then,
20 mg of protein was subjected to SDS-PAGE, transferred to mem-
branes, and antigens were detected using primary antibodies. All
antibodies were from Sigma Aldrich except for isoform-speciﬁc
antibodies against M1 (rabbit polyclonal; #AP7476b; Proteintech,
Chicago, IL) and M2 (rabbit polyclonal; #15821-1-AP; Proteintech),
which were generated using antigen-speciﬁc peptides. Immuno-
blot signals were quantiﬁed with an image analyzer (Multi Gauge
Ver.3; FUJIFILM, Fuji, Tokyo, Japan). Results were expressed as
means and standard deviations for 3 independent experiments.
3.8. Immunocytochemistry
Cells were ﬁxed with 4% paraformaldehyde at room tempera-
ture for 30 min and then treated successively with 0.3% Triton X-
100 (Wako Chemical) in PBS (Sigma Aldrich, Tokyo, Japan) for
15 min, followed by 3% bovine serum albumin (Sigma Aldrich) for
30 min to reduce nonspeciﬁc binding. Samples were reacted
overnight with anti-PDX1 (#ab47308; Abcam, Tokyo, Japan) anti-
bodies (1:200 dilution) at 4 C, followed by reaction with Alexa
Fluor 488 conjugated anti-guinea pig IgG antibody (#ab150185;
Abcam) at room temperature for 1 h. Cell nuclei were stained with
DAPI for 10 min. Photomicrographs were acquired with a ﬂuores-
cence microscope (BZ-9000, Keyence, Osaka, Japan).
3.9. In-gel digestion and mass spectrometric protein identiﬁcation
After immunoprecipitation, capillary electrophoresis (CE) and
LC-MS analyses [Human Metabolome Technologies (HMT), Yama-
gata, Japan], in-gel digestion, and mass spectrometric protein
identiﬁcation were performed. Peptides were puriﬁed with ZipTip
(Millipore Corporation, Billerica, MA), according to the manufac-
turer's instructions, and analyzed with an Ultraﬂex tof/tof (Bruker
Daltonics, Bremen, Germany) MALDI mass spectrometer and
MASCOT software (Matrix Science, Boston, MA).
3.10. Nontargeted metabolome analysis
For nontargeted metabolome analysis, cells cultured on a dish
(106 cells/sample) were used for metabolite extraction. Cells were
washed twice with a 5% mannitol solution and treated with 800 mL
of methanol. Cell extracts were treatedwith 550 mL of Milli-Q water
that contained internal standards (H3304-1002; Human Metab-
olome Technologies, Inc., Tsuruoka, Japan) and allowed to rest for
another 30 s. Extracts were collected and centrifuged at 2,300 g at
4 C for 5 min. Then, 800 mL of the upper aqueous layer was ﬁltered
by centrifugation using a Millipore 5-kDa cutoff ﬁlter at 9,100 g at
4 C for 120 min to remove proteins before being subjected to
CEeMS.
Peaks were extracted using automatic integration software
MasterHands (Keio University, Tsuruoka, Japan) to obtain peak in-
formation, including m/z ratios, migration time for CE-TOFMS
measurements (MT), and peak areas. Signal peaks that corre-
sponded to isotopomers, adduct ions, and other product ions ofknown metabolites were excluded, and the remaining peaks were
annotated with putative metabolites from the HMT metabolite
database based on their MT and m/z values determined by MS. The
tolerance range for peak annotation was conﬁgured at ±0.5 min for
MT and ±10 parts/million for m/z ratios. Peak areas were normal-
ized against those of the internal standards and the relative area
values were further normalized by sample amounts. Hierarchical
cluster analysis (HCA) and principal component analysis (PCA)
were performed using our proprietary software, PeakStat and
SampleStat, respectively. Detected metabolites were plotted on
metabolic pathway maps using Visualization and Analysis of Net-
works containing Experimental Data (VANTED) software.3.11. Luciferase assay
WT mouse Pdx1 promoter sequence and a mutant sequence
with a FOXO4 binding site substitution were synthesized (Ynitech,
Chiba, Japan). In the wild-type DNA fragment, the Pdx1 promoter
(4.5 kbe0.1 kb) was changed to the sequence 50-AGTGCTAC-
GACGGTGGGCGG-30 at the position1996 to1977. Each fragment
of Pdx1 promoter DNAwas cloned into a pGL4.20 [luc2/Puro] vector
(E6751, Promega, Tokyo, Japan). A total of 1 105 cells were grown
in 6-well plates. After 24 h, the luciferase vector was transfected
using Lipofectamine 2000 (Life Technologies, 11668027). At day 2,
luciferase luminescence was measured using a Luciferase Assay
System (E1500, Promega).3.12. Statistical analysis
Results for categorical variables were compared by a Chi-square
test. Results for continuous variables (medians/interquartile
ranges) were compared using a Wilcoxon test. Statistical analyses
were performed with JMP (JMP version 8.01, SAS Institute, Cary,
NC). P-values of <0.05 were considered signiﬁcant.Acknowledgments
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